Homestead Associates in Research,Inc

Miami, Florida 33033

5 studies enrolling now · 21 studies all time

What they study most

Acute Respiratory Infection, Alzheimer's Disease Psychosis, Arthritis, Rheumatoid, Celiac Disease, Chronic Gout, Chronic Kidney Diseases, Coeliac Disease, Covid19, Crohn's Disease, Essential Tremor, Gout, Gout Flare

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis — Enrolling by invitation
• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
• Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant — Paused
• Department of Defense PTSD Adaptive Platform Trial - Master Protocol — Paused
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002 — Paused
• Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine — Paused
• A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II — Completed
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD — Completed
• A Study of Acute Respiratory Infections in Global Outpatient Setting — Completed
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed